# Epidemiological Cluster Evaluation in Patients Admitted to Internal Medicine, With at Least One of the Following Diagnoses: Heart Failure, COPD, Renal Failure. The FADOI IN-CluDiMI Study

> **NCT07660757** · — · COMPLETED · sponsor: **Fadoi Foundation, Italy** · enrollment: 4500 (actual)

## Conditions studied

- Heart Failure
- Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Kidney Disease (CKD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07660757
- **Lead sponsor:** Fadoi Foundation, Italy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-02
- **Primary completion:** 2024-06-03
- **Final completion:** 2024-11-19
- **Target enrollment:** 4500 (ACTUAL)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660757, "Epidemiological Cluster Evaluation in Patients Admitted to Internal Medicine, With at Least One of the Following Diagnoses: Heart Failure, COPD, Renal Failure. The FADOI IN-CluDiMI Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07660757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*